Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.11.4437

Lack of Influence of the SMAD7 Gene rs2337107 Polymorphism on Risk of Colorectal Cancer in an Iranian Population  

Akbari, Zahra (Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences)
Safari-Alighiarloo, Nahid (Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences)
Haghighi, Mahdi Montazer (Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Shahid Beheshti University of Medical Sciences)
Vahedi, Mohsen (Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences)
Mirtalebi, Hanieh (Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences)
Azimzadeh, Pedram (Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences)
Milanizadeh, Saman (Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences)
Shemirani, Atena Irani (Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences)
Nazemalhosseini-Mojarad, Ehsan (Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences)
Aghdaei, Hamid Asadzadeh (Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Shahid Beheshti University of Medical Sciences)
Zali, Mohammad Reza (Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.11, 2014 , pp. 4437-4441 More about this Journal
Abstract
SMAD7 has been identified as a functional candidate gene for colorectal cancer (CRC). SMAD7 protein is a known antagonist of the transforming growth factor beta ($TGF-{\beta}$) signaling pathway which is involved in tumorigenesis. Polymorphisms in SMAD7 may thus alter cancer risk. The aim of this study was to investigate the influence of a SMAD7 gene polymorphism (rs2337107) on risk of CRC and clinicopathological features in an Iranian population. In total, 210 subjects including 105 patients with colorectal cancer and 105 healthy controls were recruited in our study. All samples were genotyped by TaqMan assay via an ABI 7500 Real Time PCR System (Applied Biosystems) with DNA from peripheral blood. The polymorphism was statistically analyzed to investigate the relationship with the risk of colorectal cancer and clinicopathological properties. Logistic regression analysis revealed that there was no significant association between rs2337107and the risk of colorectal cancer. In addition, no significant association between genotypes and clinicopathological features was observed (p value>0.05). Although there was not any association between genotypes and disorder, CT was the most common genotype in this population. This genotype prevalence was also higher in the patients with well grade (54.9%) and colon (72.0%) tumors. Our results provide the first evidence that this polymorphism is not a potential contributor to the risk of colorectal cancer and clinicopathological features in an Iranian population, and suggests the need of a large-scale case-control study to validate our results.
Keywords
Colorectal cancer; SMAD7; TNM stage; single nucleotide polymorphism;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Azadeh S, Moghimi-Dehkordi B, Fatem S, et al (2007). Colorectal cancer in Iran: an epidemiological study. Asian Pac J Cancer Prev, 9, 123-6.
2 Gaasenbeek M, Howarth K, Rowan AJ, et al (2006). Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers. Cancer Res, 66, 3471-9.   DOI   ScienceOn
3 Boulay JL, Mild G, Lowy A, et al (2003). SMAD7 is a prognostic marker in patients with colorectal cancer. Int J Cancer, 104, 446-9.   DOI
4 Broderick P, Carvajal-Carmona L, Pittman AM, et al (2007). A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nature Genetics, 39, 1315-7.   DOI   ScienceOn
5 Derynck R, Akhurst RJ, Balmain A (2001). TGF-$\beta$ signaling in tumor suppression and cancer progression. Nature Genetics, 29, 117-29.   DOI   ScienceOn
6 Green MR, Sambrook J (2012). Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory Press.
7 Haerian MS, Haerian BS, Rooki H, et al (2014). Association of 8q24.21 rs10505477-rs6983267 haplotype and age at diagnosis of colorectal cancer. Asian Pac J Cancer Prev, 15, 369-74.   DOI
8 Haghighi MM, Vahedi M, Mohebbi SR, et al (2009). Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer. Asian Pac J Cancer Prev, 10, 497-500.
9 Halder S, Rachakonda G, Deane N, et al (2008). SMAD7 induces hepatic metastasis in colorectal cancer. Br J Cancer, 99, 957-65.   DOI
10 Halder SK, Beauchamp RD, Datta PK (2005). SMAD7 induces tumorigenicity by blocking TGF-$\beta$-induced growth inhibition and apoptosis. Experimental Cell Res, 307, 231-46.   DOI
11 Hong S, Lim S, Li AG, et al (2007). SMAD7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nature Immunology, 8, 504-13.   DOI   ScienceOn
12 Levy L, Hill CS (2006). Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev, 17, 41-58.   DOI   ScienceOn
13 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. Cancer J Clin, 61, 69-90.   DOI
14 Jiang X, Castelao JE, Vandenberg D, et al (2013). Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry. PloS one, 8, 60464.   DOI
15 Kirk BW, Feinsod M, Favis R, et al (2002). Single nucleotide polymorphism seeking long term association with complex disease. Nucleic Acids Res, 30, 3295-311.   DOI
16 Li X, Yang X-x, Hu N-y, et al (2011). A risk-associated single nucleotide polymorphism of SMAD7 is common to colorectal, gastric, and lung cancers in a Han Chinese population. Molecular Biology Reports, 38, 5093-7.   DOI   ScienceOn
17 Moghimi-Dehkordi B, Safaee A (2012). An overview of colorectal cancer survival rates and prognosis in Asia. World J Gastrointestinal Oncol, 4, 71.   DOI
18 Lichtenstein P, Holm NV, Verkasalo PK, et al (2000). Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. New Eng J Med, 343, 78-85.   DOI   ScienceOn
19 Massague J (2008). TGF$\beta$ in cancer. Cell, 134, 215-30.   DOI   ScienceOn
20 Milanizadeh S, Khanyaghma M, Haghighi MM, et al (2013). Molecular analysis of imperative polymorphisms of MLH1 gene in sporadic colorectal cancer. Cancer Biomark, 13, 427-32.
21 Nassiri M, Kooshyar MM, Roudbar Z, et al (2013). Genes and SNPs associated with non-hereditary and hereditary colorectal cancer. Asian Pac J Cancer Prev, 14, 5609-14.   과학기술학회마을   DOI   ScienceOn
22 Pittman AM, Naranjo S, Webb E, et al (2009). The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression. Genome Res, 19, 987-93.   DOI
23 Rizzo A, Waldner MJ, Stolfi C, et al (2011). SMAD7 expression in T cells prevents colitis-associated cancer. Cancer Res, 71, 7423-32.   DOI
24 Shemirani AI, Haghighi MM, Zadeh SM, et al (2011). Simplified MSI marker panel for diagnosis of colorectal cancer. Asian Pac J Cancer Prev, 12, 2101-4.
25 Stolfi C, Marafini I, De Simone V, et al (2013). The dual role of SMAD7 in the control of cancer growth and metastasis. Int J Molecular Sci, 14, 23774-90.   DOI
26 Tomlinson IP, Webb E, Carvajal-Carmona L, et al (2008). A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23. 3. Nature Genetics, 40, 623-30.   DOI   ScienceOn
27 Tenesa A, Dunlop MG (2009). New insights into the aetiology of colorectal cancer from genome-wide association studies. Nature Reviews Genetics, 10, 353-8.
28 Tenesa A, Farrington SM, Prendergast JG, et al (2008). Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nature Genetics, 40, 631-7.   DOI   ScienceOn
29 Thompson CL, Plummer SJ, Acheson LS, et al (2009). Association of common genetic variants in SMAD7 and risk of colon cancer. Carcinogenesis, 30, 982-6.   DOI
30 Xu Y, Pasche B (2007). TGF-$\beta$ signaling alterations and susceptibility to colorectal cancer. Human Molecular Genetics, 16, 14-20.   DOI
31 Yan X, Chen Y (2011). SMAD7: not only a regulator, but also a cross-talk mediator of TGF-beta signalling. Biochem J, 434, 1-10.   DOI
32 Slattery ML, Herrick J, Curtin K, et al (2010). Increased risk of colon cancer associated with a genetic polymorphism of SMAD7. Cancer Res, 70, 1479-85.   DOI
33 Song Q, Zhu B, Hu W, et al (2012). A common SMAD7 variant is associated with risk of colorectal cancer: evidence from a case-control study and a meta-analysis. PloS One, 7, 33318.   DOI